PDT Partners’s Amicus Therapeutics FOLD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-75,318
| Closed | -$1.09M | – | 544 |
|
|
2026
Q1 | $1.09M | Sell |
75,318
-374,681
| -83% | -$5.37M | 0.06% | 322 |
|
|
2025
Q4 | $6.41M | Sell |
449,999
-56,053
| -11% | -$551K | 0.42% | 60 |
|
|
2025
Q3 | $3.99M | Hold |
506,052
| – | – | 0.25% | 141 |
|
|
2025
Q2 | $2.9M | Sell |
506,052
-235,263
| -32% | -$1.52M | 0.16% | 216 |
|
|
2025
Q1 | $6.05M | Buy |
741,315
+388,817
| +110% | +$3.6M | 0.43% | 40 |
|
|
2024
Q4 | $3.32M | Buy |
352,498
+99,539
| +39% | +$1.03M | 0.29% | 112 |
|
|
2024
Q3 | $2.7M | Buy |
+252,959
| New | +$2.75M | 0.24% | 140 |
|
|
2022
Q4 | – | Sell |
-30,505
| Closed | -$318K | – | 723 |
|
|
2022
Q3 | $318K | Buy |
+30,505
| New | +$340K | 0.05% | 566 |
|
|
2022
Q2 | – | Sell |
-32,921
| Closed | -$312K | – | 1021 |
|
|
2022
Q1 | $312K | Buy |
+32,921
| New | +$309K | 0.03% | 713 |
|
|
2019
Q3 | – | Sell |
-316,400
| Closed | -$3.95M | – | 465 |
|
|
2019
Q2 | $3.95M | Hold |
316,400
| – | – | 0.23% | 129 |
|
|
2019
Q1 | $4.3M | Sell |
316,400
-22,000
| -7% | -$269K | 0.24% | 125 |
|
|
2018
Q4 | $3.24M | Buy |
338,400
+245,816
| +266% | +$2.7M | 0.18% | 155 |
|
|
2018
Q3 | $1.12M | Buy |
+92,584
| New | +$1.29M | 0.05% | 301 |
|
|
2015
Q3 | – | Sell |
-227,026
| Closed | -$3.21M | – | 1365 |
|
|
2015
Q2 | $3.21M | Buy |
227,026
+92,357
| +69% | +$1.11M | 0.08% | 293 |
|
|
2015
Q1 | $1.47M | Buy |
134,669
+35,402
| +36% | +$312K | 0.04% | 580 |
|
|
2014
Q4 | $826K | Sell |
99,267
-14,033
| -12% | -$96.3K | 0.08% | 374 |
|
|
2014
Q3 | $674K | Buy |
+113,300
| New | +$594K | 0.02% | 844 |
|
Other funds holding FOLD
PDT Partners's FOLD Position: Q2 2026 in Review
PDT Partners sold out of Amicus Therapeutics (FOLD) in Q2 2026, closing a stake of 75,318 shares — an estimated $1.09M sold.
PDT Partners first reported a position in FOLD in Q3 2014 and held it in 17 quarters. The position peaked at $6.41M in Q4 2025. 2 funds tracked by Wall St. Rank hold FOLD as of Q2 2026.
- PDT Partners reported no remaining Amicus Therapeutics position as of Q2 2026 after selling out during the quarter.
- PDT Partners sold 75,318 Amicus Therapeutics shares in Q2 2026, an estimated $1.09M.
- PDT Partners first reported a position in Amicus Therapeutics in Q3 2014 and held it in 17 quarters.
- PDT Partners's Amicus Therapeutics position peaked at $6.41M in Q4 2025.
- 2 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q2 2026.
Based on PDT Partners's 13F filing for Q2 2026, filed 14 Aug 2026.